103-113, Stanley Street
West Melbourne, VIC 3003
61 3 8379 0100
Full Time Employees:
|Mr. Michael John Kotsanis B.Sc., BSc, GradDipBus, MBus||CEO, MD & Exec. Director||342.8k||N/A||1966|
|Ms. Joanna Johnson B.E., BEc, ICAA||CFO & Company Sec.||188.18k||N/A||N/A|
Acrux Limited, together with its subsidiaries, develops and commercializes generic and topical pharmaceuticals in Australia, Europe, the United States, and internationally. The company offers testosterone solutions, such as oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels for treatment of adult males who have low or no testosterone. It also provides estradiol sprays for women under the Evamist and Lenzetto brand names for the treatment of flushes associated with menopause. The company was incorporated in 1998 and is based in West Melbourne, Australia.
Acrux Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.